Soleno Therapeutics (SLNO) Financials

$53.01

$0.00 (0.00%)

As on 18-May-2026 09:30EDT

Market cap

$2,763 Mln

Revenue (TTM)

$285 Mln

P/E Ratio

27.5

P/B Ratio

5.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	285.01	190.41	--	--	--	--
Cost of Revenue	3.90	2.70	1.99	1.96	2.21	2.21
Gross Profit	281.11	187.71	-1.99	-1.96	-2.21	-2.21
Operating Expenses	193.34	172.76	187.67	41.38	24.40	31.53
Operating Profit (EBIT)	87.77	14.95	-187.67	-41.38	-24.40	-31.53
Other Income	--	--	--	--	--	--
Profit before Tax	99.58	20.89	-175.85	-38.99	-24.07	-30.91
Provision for Tax	3.54	--	-175.85	2.71	-3.75	-1.35
Profit after Tax (Net Income)	96.04	20.89	-175.85	-38.99	-24.07	-30.91
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-24.07	-30.91

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	495.80	450.12	245.11	157.51	10.35	17.79
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	54.54	52.35	67.11	11.68	8.84	9.75
Current Liabilities	58.05	61.36	18.75	11.51	7.31	8.01
Total Liabilities	666.44	563.83	330.97	180.69	26.50	35.55

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	282.01	208.02	37.08	9.33	10.85	13.13
Current Assets	326.38	355.81	293.89	171.36	15.65	22.42
Total Assets	666.44	563.83	330.97	180.69	26.50	35.55
Total Debt*	4.41	2.69	52.83	0.40	0.16	0.46
Net Current Assets	268.33	294.45	275.14	159.85	8.33	14.42

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	46.80	-69.10	-24.94	-20.78	-27.77
Cash Flow from Investing Activities	--	-201.78	-225.68	--	-0.01	-0.02
Cash from Financing Activities	--	137.16	213.03	180.02	14.09	-0.13
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	1.77	0.38	-4.00	-1.48	-2.55	-5.80
Cash EPS ($)	--	0.42	-3.96	-1.41	-2.34	-5.43
Adjusted Book Value ($)	--	8.28	5.58	5.98	1.10	3.34
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.86	-1.57	-0.95	-2.20	-5.21
Free Cash Flow per Share ($)	--	0.86	-1.58	-0.95	-2.20	-5.22

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	5.57	-77.15	-46.30	-167.41	-96.69
ROE (%)	19.39	6.01	-87.35	-46.45	-171.05	-97.60
ROA (%)	19.20	4.67	-68.74	-37.64	-77.57	-61.49
EBIT Margin (%)	36.84	13.85	--	--	--	--
Net Margin (%)	33.70	10.97	--	--	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	154.23	115.01	-350.44	-62.00	25.39	-30.93
Net Profit Growth (%)	148.45	111.88	-351.04	-62.00	22.14	-25.45
EPS Growth (%)	138.33	1.10	-1.71	0.42	0.56	-0.25
Book Value Growth (%)	85.76	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	27.47	120.42	-11.23	-27.20	-0.78	-0.07
Price / Book Value	5.57	5.59	8.06	6.73	1.81	0.12
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	23.94	77.96	-10.00	-24.07	-0.19	0.62
Close Price ($)	33.48	46.30	44.95	40.25	1.98	6.15
High Price ($)	90.32	90.32	60.92	40.74	7.20	50.40
Low Price ($)	29.43	41.50	35.70	1.78	0.85	6.02
Market Cap ($ Cr)	2,762.89	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.10	0.01	0.22	0.00	0.01	0.03
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.01	0.02
Current Ratio	5.62	5.80	15.68	14.89	2.14	2.80
Quick Ratio	5.32	5.55	15.68	--	--	--
Interest Coverage	19.42	4.81	-760.26	--	-72.93	-52.20

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	16.54	14.81	--	--	--	--
Asset Turnover	0.57	0.43	--	--	--	--
Receivable days	--	27.06	--	--	--	--
Inventory Days	--	1,016.21	--	--	--	--
Payable days	--	1,441.86	1,105.77	459.45	415.74	557.97
Cash Conversion Cycle	--	-398.60	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.